SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-007332
Filing Date
2017-04-26
Accepted
2017-04-26 17:15:54
Documents
8
Period of Report
2017-06-08
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A opgn-def14a_20170608.htm DEF 14A 982500
2 GRAPHIC g201704252332316531044.jpg GRAPHIC 7483
3 GRAPHIC g201704252332372211046.jpg GRAPHIC 2152
4 GRAPHIC g201704252332318741045.jpg GRAPHIC 7483
5 GRAPHIC g201704252332316501043.jpg GRAPHIC 3888
6 GRAPHIC g201704252332316441042.jpg GRAPHIC 7483
7 GRAPHIC g201704252332372301047.jpg GRAPHIC 93402
8 GRAPHIC g201704252332372601048.jpg GRAPHIC 34475
  Complete submission text file 0001564590-17-007332.txt   1200053
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37367 | Film No.: 17785398
SIC: 8071 Services-Medical Laboratories